Evidence map›Paper›PMID 33681196›Full record

ArticleFrontiers in cell and developmental biology2021

Hypoglycemic Efficacy of Rh-aFGF Variants in Treatment of Diabetes in ZDF Rats.

Li Zhang, Qingde Zhou, Min Chen, Xuanxin Yang, Chao Lu, Wenzhe Sun, Qi Hui, Xiaojie Wang

Open access · goldAbstract read
In one paragraph

Article in Frontiers in cell and developmental biology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 99% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Li ZhangThe First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
Qingde ZhouThe First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
Min ChenThe First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
Xuanxin YangThe First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
Chao LuThe First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
Wenzhe SunThe First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
Qi HuiThe First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
Xiaojie WangThe First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
First Affiliated Hospital of Wenzhou Medical University · CNWenzhou Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Acidic fibroblast growth factor (aFGF) is a promising regulator of glucose with no adverse effects of hypoglycemia. Previous researches revealed that aFGF mediated adipose tissue remodeling and insulin sensitivity. These findings supported rh-aFGF

Indexed as

aFGFhypoglycemic effectinsulin resistancesafetytype 2 diabetes

Identifiers

PMID33681196
PMCPMC7930327
OpenAlexW3132442354

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.